Covered recipient · General Payments record
FRIEDA KLEIN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,302.49
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $869.74 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $288.28 | 2 |
| Alkermes, Inc. | $120.00 | 1 |
| Biogen, Inc. | $114.96 | 2 |
| Blueprint Medicines Corporation | $109.37 | 1 |
| Astellas Pharma US Inc | $90.25 | 4 |
| Exeltis, USA Inc. | $53.76 | 3 |
| CooperSurgical, Inc. | $37.10 | 2 |
| Exact Sciences Corporation | $32.80 | 1 |
| PFIZER INC. | $23.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $120.00 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120532828 | CMS |
| Astellas Pharma US Inc | $24.43 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139469652 | CMS |
| Astellas Pharma US Inc | $22.49 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139486160 | CMS |
| Astellas Pharma US Inc | $26.77 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139516757 | CMS |
| Astellas Pharma US Inc | $16.56 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139538952 | CMS |
| Biogen, Inc. | $14.96 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104851506 | CMS |
| Biogen, Inc. | $100.00 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104833911 | CMS |
| Blueprint Medicines Corporation | $109.37 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147447996 | CMS |
| CooperSurgical, Inc. | $18.50 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150787603 | CMS |
| CooperSurgical, Inc. | $18.60 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150787617 | CMS |
| Exact Sciences Corporation | $32.80 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114737522 | CMS |
| Exeltis, USA Inc. | $21.64 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014799 | CMS |
| Exeltis, USA Inc. | $14.62 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014801 | CMS |
| Exeltis, USA Inc. | $17.50 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150014803 | CMS |
| GENZYME CORPORATION | $148.63 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139902414 | CMS |
| GENZYME CORPORATION | $139.65 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139902466 | CMS |
| PFIZER INC. | $23.22 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131042942 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.